The new facility, located in Msheireb Downtown Doha, moves away from reactive disease management in favor of proactive health optimization. Instead of standardized treatments, the program utilizes advanced diagnostic testing to assess metabolic function, hormone balance, and cognitive performance. These findings generate a personalized biological blueprint for each patient, overseen by a physician-led team.

Graham Galka, CEO of Cenegenics, stated that the move into the Middle East reflects a shared commitment to setting higher standards for preventive care. Aman Clinics, a subsidiary of Aman Hospital, views the partnership as a vital step in integrating global medical innovations into the local market. Executive Director Gizele Alkoussa noted that the initiative aims to empower individuals to take a data-driven approach to long-term wellness, moving beyond traditional clinical boundaries to address aging and physical performance through evidence-based protocols developed over the last three decades.